We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Science Group Plc | LSE:SAG | London | Ordinary Share | GB00B39GTJ17 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
3.00 | 0.74% | 410.00 | 400.00 | 420.00 | 410.00 | 407.00 | 407.00 | 31,634 | 10:08:38 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Business Consulting Svcs,nec | 98.82M | 10.56M | 0.2322 | 17.66 | 186.38M |
Date | Subject | Author | Discuss |
---|---|---|---|
13/11/2011 19:09 | I have all Of the House Broker notes, so I go with those! | hastings | |
13/11/2011 19:07 | Arbuthnot note on 9th Nov has the following with a Strong Buy and 125p target: 2011: 6.7p 2012: 7.4p 2013: 8.1p We have valued Sagentia on the basis of a sum-of-the-parts analysis. This is derived either by implying a conservative 9.8x P/E on the 6.7p of diluted EPS we forecast for FY2011 and then adding the 59.2p of NAV , which is essentially the net cash plus the freehold property or alternatively, from a trading point of view, valuing the revenues of the company on an EV/sales multiple of 1.3x, which equates to £30.6m, the net realisable value of the property at £11.4m (which is probably overly conservative), with last reported net cash of £10.1m. If we divide the total £52.1m by the 41.7m shares in issue, we calculate a value of 125p per share. | doubleorquits | |
13/11/2011 18:34 | I have even different figures to you guys. According to Company REFS i have Arbuthnots forecast as 7.4p and 8.3 for YE 2011 and 1012 respectively. That is dated from Sept 27th. | cfro | |
13/11/2011 18:20 | Yes and we are basically at the year end nearly so the 8.6p eps will be the current year eps from Jan 1. If SAG beat the 7.7p eps forecast for this year by anything meaningful then that 8.6p is likely to look very conservative for the year starting Jan 1. I think that would mean a single digit PEfor the new year, £10m net cash at least on a mkt cap of £39m. Tangible assets are likely to rise too with Sphere's float. They have enough cash to give every shareholder 20p a share or do a share buy back. Way to cheap imo - but everyone here feels that I'm sure. CR | cockneyrebel | |
13/11/2011 17:17 | Ditto CR-what is interesting is the subsequent note, which mentioned the recent significant contract underpins the forecasts for 2011-2012 at the very least! | hastings | |
13/11/2011 16:07 | 7.7p EPS and 8.6p are the Digital Look EPS numbers for this year and next year. The August note from Arbuthnot. I don't think there's been any change in that time, I think you might just be looking at one number being an adjusted eps and the other a non-adjusted eps number. CR | cockneyrebel | |
13/11/2011 15:35 | Hastings, I accessed the forecasts from TDW, I have since looked at other online brokers and financial sites and have found the forecasts to be very variable. I do find it unlikely that Arbuthnot would raise their target price from 110p to 125p, but at the same time lower their earning forecasts. So I have sent Arbuthnot a message pointing out that many online sites are showing different forecasts. It looks like a communication error. Much prefer your forecasts to TDWs. ic2... | interceptor2 | |
13/11/2011 13:51 | Interceptor-there appears to be some discrepancy in the Arbuthnot numbers you have put up. Arbuthnot forecasts from 11th November. 2011, PBT = £3.21m and EPS = 6.7p 2012, PBT = £6.60m and EPS = 7.4p As you will see below is an extract from the note in August, you will see that the EPS figures are different from above, where did you access those from. We have been upgrading our PBT forecasts on a regular basis over the last 12-15 months and on the interims increased our 2011 PBT forecast for the third time in recent months to PBT of £3.2m giving EPS of 7.7p on revenues of £23.5m. The revenue growth has been driven by a particularly strong performance from the Medical Sector and an improving performance in the Consumer Sector. As well as stronger revenue growth, profits are also being driven by an improving operating margin. The latter is as a result of the establishment of a high utilisation, tight cost control and lower-risk consultancy operating model. For 2012 we have a PBT forecast of £3.6m on revenues of £25.0m (£24.7m) leading to EPS of 8.6p. | hastings | |
12/11/2011 16:44 | I agree that it's always best to underpromise and over deliver, and it's often the case to see brokers forecast between 10 to 20% below actual results. Interesting this time last year Arbuthnot were forecasting 60% below the actual results issued in February. Will be could to have Numis researching SAG. ic2... | interceptor2 | |
12/11/2011 12:37 | Agree CR. It is also worth noting that Arbuthnot state that the recent contract win underpins the recent forecasts, leaving plenty of room for upside. Numis should complete their research very soon,so let's see what they bring to the table. On another matter CCL in Cambridge is doing very well at the moment,not a complete comparison, but as near as you can get,also has an office in Cambridge Mass,like SAG. | hastings | |
12/11/2011 12:00 | A lot of brokers are over cautious at the moment interceptor, due to the market. A lot of co's like to get everything under the belt before giving the nod to brokers too imo. Undevalued on assets and earnings imo. CR | cockneyrebel | |
12/11/2011 11:44 | Arbuthnot forecasts from 11th November. 2011, PBT = £3.21m and EPS = 6.7p 2012, PBT = £6.60m and EPS = 7.4p Am I alone in thinking that Arbuthnot calculations are a complete waste of space, and it's about time SAG had a decent broker following them. They did the same with IDG last week, which I posted a comment about. How can they lower their EPS figures after a substantal contract win after their last forecasts, and we know there is no more dilution from now, and SAG still had £27.4m of unused tax credits reported February 2011. They have a history of being so far behind the curve with SAG before. 21st July 2010 day of Interims Arbuthnot forecast PBT = £1.20m and EPS = 2.8p another 3 upgrades later and they were forecasting EPS = 6.2p on 14 January 2011 which SAG beat in February with 7.0p EPS. Arbuthnot are best ignored imho. ic2... | interceptor2 | |
11/11/2011 13:12 | Electronica-it appears that Sphere has had little trouble in attracting interest, which is certainly a very good sign. | hastings | |
11/11/2011 10:12 | Noted thanks. | truffle | |
11/11/2011 09:55 | Truffle Sagentia holds 5.8% of Sphere prior to the placing on Monday. I don't expect SAG to participate in the placing so they will be diluted. We will have to wait until Tuesday to find out how big the dilution is & what the Sphere striking price is. In the medium term I see SAG selling down the Sphere holding, but I don't expect that they will be disposing of any shares at the placing. It must be difficult enough getting new money raised for Sphere without the extra burden of selling by founding shareholders. | electronica | |
11/11/2011 09:23 | Can someone just clarify when exactly Sphere Medical starts trading, and is it correct to say that Sagentia's stake will be worth 5.8% of the capitalised value of the company? | truffle | |
10/11/2011 23:39 | Yes, nice little write up today (in shares) and with the UK-analyst comments as well SAG are starting to get noticed. Not surprised to see a little pullback after the recent climb and it is near the top of it's (rising) range. There has been a fair bit of selling absorbed of late and like CR says I think some larger orders are being filled as it has held up well. Plenty of news to come here - looks a good one. | greenroom78 | |
10/11/2011 22:46 | Cheers truffle and CR. The shares have stood up very well in turbulent times and should continue to do so. Sphere attracted some highly respectable institutions who wouldn't be investing in forlorn hopes right now.Clearly, as others have pointed out, SAG will no doubt look for an early exit given the revised strategy. Numis note should be out very soon now, but I still have an inkling for an acquisition!! | hastings | |
10/11/2011 18:32 | And just seen a really good write-up on Sagentia in this weeks Shares magazine. It has been rated one of their 5 Top Tips, and a Buy under the 'Brains of Britain five companies with a cutting edge' report, which is their cover story. The article is worth reading. | truffle | |
10/11/2011 18:22 | Cheers Electronica - a trading update here can't be far off - what target from Arbuthnot when the co comes out ahead of forecasts - as I suspect they will be? Will be intteresting to see what SAG's stake in Sphere is worth next week. CR | cockneyrebel | |
10/11/2011 18:12 | This from UK Analyst's Newsletter today ........... "Sagentia (SAG) kept its "strong buy" rating from Arbuthnot Securities, with an increased target price of 125p from 110p. The broker is impressed with technology consultant's ability to improve its margins, growing from a 0.3 million pounds pre-tax loss in 2009 to an expected 3.2 million pound pre-tax profit in 2011, on fairly constant revenues of 23.4 million pounds and 23.5 million pounds respectively. Arbuthnot adds that the recent 10 million dollar (6.3 million pound) contract win, which will last three years, improves revenue visibility. Shares in Sagentia slipped 0.5p to 92.p." | electronica | |
10/11/2011 17:49 | Sphere Medical entera AIM on Tuesday - seems SAG have 5.8% after the increase in shares in the float. Will be interesting next week. CR | cockneyrebel | |
09/11/2011 07:00 | The encouraging thing about last Fridays break up over 88p, is that sellers emerged on Friday, 7 transactions of 100k shares. But the share price increased slightly during the selling. So investors that brought at July's high of 88p, and were waiting for an opportunity to break even after the share price went to 74p a few weeks afterwards could very likely be out now. Very positive imo. ic2... | interceptor2 | |
07/11/2011 22:06 | Well you can't ask for better than that. | hastings | |
07/11/2011 22:01 | It has rated 9 on the piotroski screen. | russman |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions